Lancet[journal] 检索结果

141. Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trials.

作者: Nelson Wang.;Abdul Salam.;Rashmi Pant.;Amit Kumar.;Rupasvi Dhurjati.;Faraidoon Haghdoost.;Kota Vidyasagar.;Prachi Kaistha.;Hariprasad Esam.;Sonali R Gnanenthiran.;Raju Kanukula.;Paul K Whelton.;Brent Egan.;Aletta E Schutte.;Kazem Rahimi.;Otavio Berwanger.;Anthony Rodgers.
来源: Lancet. 2025年406卷10506期915-925页

We aimed to quantify the blood pressure-lowering efficacy of antihypertensive drugs and their combinations from the five major drug classes.

142. Estimating the benefits of personalised glycaemic control - Authors' reply.

作者: Pedro Cardoso.;Trevelyan J McKinley.;Angus G Jones.;Andrew T Hattersley.;John M Dennis.
来源: Lancet. 2025年406卷10506期914页

143. Estimating the benefits of personalised glycaemic control.

作者: David van Klaveren.;Patrick W Serruys.;David M Kent.
来源: Lancet. 2025年406卷10506期913-914页

144. Hidradenitis suppurativa: complexity in pathogenesis and management - Authors' reply.

作者: Robert Sabat.;Afsaneh Alavi.;Kerstin Wolk.;Amit Garg.
来源: Lancet. 2025年406卷10506期912-913页

145. Hidradenitis suppurativa: complexity in pathogenesis and management.

作者: Shauna R Campbell.;Rashmi Unwala.;Chirag Shah.
来源: Lancet. 2025年406卷10506期911-912页

146. Hidradenitis suppurativa: complexity in pathogenesis and management.

作者: Claude Bachmeyer.
来源: Lancet. 2025年406卷10506期911页

147. The Lancet Countdown Report: missing links in climate action - Authors' reply.

作者: Ollie Jay.;Ian Hamilton.;Marina Romanello.
来源: Lancet. 2025年406卷10506期910页

148. Hidradenitis suppurativa: complexity in pathogenesis and management.

作者: Jieying Tang.;Xiaoyin Bai.
来源: Lancet. 2025年406卷10506期910-911页

149. The Lancet Countdown Report: missing links in climate action.

作者: Tormod Rogne.;Kai Chen.;Jeanette H Magnus.
来源: Lancet. 2025年406卷10506期909页

150. The Lancet Countdown Report: missing links in climate action.

作者: Jie-Yu Chuang.
来源: Lancet. 2025年406卷10506期909-910页

151. Why are we failing to rapidly diagnose tuberculosis in the UK?

作者: Francis Drobniewski.;Onn Min Kon.;Ximena Gonzalo.;Marcia Ashmi.
来源: Lancet. 2025年406卷10506期908-909页

152. Using big picture trends for global health.

作者: Tim Colbourn.
来源: Lancet. 2025年406卷10506期890-891页

153. Endoscopic sinus surgery versus macrolides in chronic rhinosinusitis: redefining clinical priorities.

作者: Zhenxiao Huang.;Bing Zhou.
来源: Lancet. 2025年406卷10506期887-889页

154. Better blood pressure control with predictable drug dosing.

作者: Mattias Brunström.;Reinhold Kreutz.
来源: Lancet. 2025年406卷10506期886-887页

155. The dialogue around NCDs needs to change.

作者: The Lancet.
来源: Lancet. 2025年406卷10506期885页

156. Resident doctor strikes in the UK: a lived reality.

作者: Sruthi Saravanan.
来源: Lancet. 2025年406卷10506期907-908页

157. Upholding medical ethics: a letter to the Israeli Medical Association.

作者: Leon Geffen.;Mitch Besser.;Eric Goemaere.;Glenda Gray.;Peter Lloyd Sherlock.;Shabir Madhi.;Shuaib Manjra.;Max Price.;Francois Venter.
来源: Lancet. 2025年406卷10506期907页

158. Tackling cardiovascular disease in the Asia-Pacific region: a new Lancet Commission.

作者: Carolyn S P Lam.;F Aaysha Cader.;Nicholas W S Chew.;Clara K Chow.;Corina Grey.;Yuming Guo.;Adam J Nelson.;Anna Rolleston.;Mitsuaki Sawano.;Kathryn Choon Beng Tan.;Jasper Tromp.;Lijing L Yan.;Stephen J Nicholls.
来源: Lancet. 2025年406卷10507期988-989页

159. Iran and beyond: perilous threats to population health.

作者: Maziar Moradi-Lakeh.;Reza Majdzadeh.;Mohammad Reza Farzanegan.;Mohsen Naghavi.
来源: Lancet. 2025年406卷10507期1001-1002页

160. Efficacy and safety of single-anastomosis duodeno-ileal bypass with sleeve gastrectomy versus Roux-en-Y gastric bypass in France (SADISLEEVE): results of a randomised, open-label, superiority trial at 2 years of follow-up.

作者: Maud Robert.;Tigran Poghosyan.;Nicolas Romain-Scelle.;Sebastien Czernichow.;Dominique Delaunay.;Adrien Sterkers.;Litavan Khamphommala.;Andrea Lazzati.;Claire Blanchard.;Robert Caiazzo.;François Pattou.;Emmanuel Disse.; .
来源: Lancet. 2025年406卷10505期846-859页

Since 2007, single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) has been proposed as an alternative to Roux-en-Y gastric bypass (RYGB) in the treatment of obesity. We conducted a multicentre randomised trial, with the hypothesis that SADI-S could be more effective than RYGB at 2-year follow-up.

结果排序

文献格式

出版时间

出版类型

出版语言